Evidence map›Paper›PMID 40918869›Full record

ArticleCureus2025

When Carcinoembryonic Antigen Misleads: A Benign Cause of Tumor Marker Elevation.

Samer Alhasan, Azeez Alzafiri, Hisham Tharwat, Ramia Alhasan, Nadia Alrashidi

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Samer AlhasanInternal Medicine, New Jahra Hospital, Al Jahra, KWT.
Azeez AlzafiriInternal Medicine, Al Jahra Hospital, Al Jahra, KWT.
Hisham TharwatInternal Medicine, Al Jahra Hospital, Al Jahra, KWT.
Ramia AlhasanInternal Medicine, Al Jahra Hospital, Al Jahra, KWT.
Nadia AlrashidiInternal Medicine, Al Jahra Hospital, Al Jahra, KWT.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carcinoembryonic antigen (CEA) is a commonly used tumor marker, primarily for the surveillance of colorectal and other gastrointestinal malignancies. However, its diagnostic specificity is limited, as CEA levels may be elevated in several benign conditions. This case report aims to highlight the potential diagnostic confusion and psychological distress caused by incidental CEA elevation in asymptomatic individuals when tested outside of an appropriate clinical context. We describe the case of a 39-year-old Kuwaiti woman who underwent a routine health check-up at a private laboratory, during which CEA was measured despite the absence of cancer-related symptoms. Her CEA level was markedly elevated, prompting anxiety and a cascade of investigations. Clinical history, physical examination, laboratory testing, endoscopic procedures, and imaging were employed to determine the cause of elevation. The patient's elevated CEA level (49.02 ng/mL) was not associated with any detectable malignancy. Her past medical history included a laparoscopic sleeve gastrectomy a year earlier. Clinical assessment revealed chronic dyspepsia, anemia, and right upper quadrant tenderness. A comprehensive workup, including colonoscopy, upper gastrointestinal (GI) endoscopy, and contrast-enhanced CT imaging excluded neoplastic processes. Abdominal ultrasound revealed chronic calculous cholecystitis. Following laparoscopic cholecystectomy, her symptoms improved and repeat CEA levels normalized, confirming a benign inflammatory etiology. This case illustrates the limitations of CEA as a screening tool and the importance of interpreting tumor markers within the appropriate clinical context. Routine ordering of tumor markers in asymptomatic patients can result in unnecessary anxiety, diagnostic delays, and resource use. Clinicians should rely on symptom-guided evaluations rather than indiscriminate testing.

Indexed as

anxietycarcinoembryonic antigencarcinoembryonic antigen (cea)ceacholecystitisdiagnostic cascadehealth screeningtumor marker

Identifiers

PMID40918869
PMCPMC12409757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.